may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful..
biohaven: "rimegepant pivotal phase 3 trial results -- conference call.".
when you peel the veneer away, they are enablers, persons of interest, co-conspirators...